These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Open trial of S-adenosylmethionine for treatment of depression. Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496 [TBL] [Abstract][Full Text] [Related]
27. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients. Fava M; Rosenbaum JF; Birnbaum R; Kelly K; Otto MW; MacLaughlin R Acta Psychiatr Scand; 1992 Jul; 86(1):42-5. PubMed ID: 1414398 [TBL] [Abstract][Full Text] [Related]
28. Early behavioural changes during antidepressant treatment in elderly patients. Kok RM; Vink D; Westers P; Nolen WA; Heeren TJ Int J Geriatr Psychiatry; 2008 Jul; 23(7):769-71. PubMed ID: 18200609 [No Abstract] [Full Text] [Related]
30. S-Adenosyl Methionine (SAMe) for Depression in Adults. Wilson A Issues Ment Health Nurs; 2019 Aug; 40(8):725-726. PubMed ID: 30633610 [No Abstract] [Full Text] [Related]
31. Results and possible developments of the clinical use of S-adenosyl-L-methionine (SAMe) in psychiatry. Agnoli A; Andreoli VM; Casacchia M; Maffei F; Fazio C Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1978; 18():170-82. PubMed ID: 357957 [No Abstract] [Full Text] [Related]
32. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients. Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421 [TBL] [Abstract][Full Text] [Related]
33. [Study of the antidepressive effects of a biological transmethylating agent (S-adenosyl-methione or SAM)]. Monaco P; Quattrocchi F Riv Neurol; 1979; 49(6):417-39. PubMed ID: 549212 [TBL] [Abstract][Full Text] [Related]
34. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387 [TBL] [Abstract][Full Text] [Related]
35. Neuropharmacology of S-adenosyl-L-methionine. Baldessarini RJ Am J Med; 1987 Nov; 83(5A):95-103. PubMed ID: 3318448 [TBL] [Abstract][Full Text] [Related]
36. Rapid antidepressant response with SAMe. A double-blind study. Potkin SG; Bell K; Plon L; Bunney WE Ala J Med Sci; 1988 Jul; 25(3):313-6. PubMed ID: 3052140 [No Abstract] [Full Text] [Related]
37. Long-term study of fluvoxamine: a new rapid-acting antidepressant. Feldmann HS; Denber HC Int Pharmacopsychiatry; 1982; 17(2):114-22. PubMed ID: 6809683 [TBL] [Abstract][Full Text] [Related]
38. Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial. Sarris J; Byrne GJ; Bousman C; Stough C; Murphy J; MacDonald P; Adams L; Nazareth S; Oliver G; Cribb L; Savage K; Menon R; Chamoli S; Berk M; Ng C; Mischoulon D Eur Neuropsychopharmacol; 2018 Oct; 28(10):1126-1136. PubMed ID: 30115553 [TBL] [Abstract][Full Text] [Related]
39. Clinical differences between early and late remission in depressive patients. Roca M; García-Toro M; García-Campayo J; Vives M; Armengol S; García-García M; Asensio D; Gili M J Affect Disord; 2011 Nov; 134(1-3):235-41. PubMed ID: 21676465 [TBL] [Abstract][Full Text] [Related]
40. Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms. Jungkunz G; Nedopil N; Rüther E Pharmacopsychiatria; 1983 May; 16(3):90-2. PubMed ID: 6351118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]